MIRA Pharmaceuticals, Inc. Common Stock

MIRA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

44M

Short interest (May 15)

1.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

2.66%

↓ 17.7%

Available Shares

↑ 0.7%

Price Chart

Company Overview

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001904286

Asset Type: CS

Market Data

Market Cap: $43,702,970

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 2.66%

Range: 2.45% - 2.68%

Available Shares 2M

Range: 1.3M - 1.6M

Recent Changes

Fee Change: ↑ 6.7%

Available Change: ↑ 3.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime